Search

The article discusses a study on lomitapide's potential in managing pediatric homozygous familial hypercholesterolemia (HoFH), which showed significant reductions in circulating lipids. It mentions that the research, presented at the 91st European Atherosclerosis Society Congress, highlights the importance of early diagnosis and treatment for HoFH, a life-limiting condition, while acknowledging concerns about the drug's adverse event profile.

The article focuses on the remarks by Dr. Betsy Mills, assistant director of aging and Alzheimer's prevention at the Alzheimer's Drug Discovery Foundation on the relationship between lipid levels and the development of dementia. Topics include finding of some studies on excessive lipid levels, reason that any dysregulation in lipid homeostasis will impact the brain according to Dr. Mills, and her explanation on high-density lipoprotein (HDL) particles in the brain.

The article focuses on the U.S. Preventive Services Task Force's (USPSTF) determination that there is insufficient evidence to recommend screening for lipid disorders in asymptomatic children and individuals aged 20 or younger. Despite conditions like familial hypercholesterolemia and multifactorial dyslipidemia that can lead to cardiovascular events, the USPSTF emphasizes the lack of evidence to support widespread lipid screening for this age group and calls for further research.

The article discusses research study on lipids reported at the 60th Annual Scientific Sessions and Expo of the American College of Cardiology on April 2-5, 2011, including one on rosuvastatin and another on the ratio of triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) as independent plasma lipid marker.

The article discusses research on drug delivery systems using lipids, and presents comments from the materials science professor Benjamin Boyd of Monash University on the potential of lipids to create special materials which could deliver drugs to the specific part of the body where they're needed and keep them there until activated by a laser beam. The potential of the drug delivery system for the treatment of macular degeneration, cancer, and diabetes is commented on, and the observation that it would need fewer injections that traditional methods is offered.

The article describes the case of a 48-year-old man, with a history of myocardial infarction (MI), who was referred by his physician for lipid management due to persistently low high-density lipoprotein cholesterol (HDL-C).

The article describes the findings of a study about the association between daily added sugar intake and dyslipidemia, published in an issue of "Journal of the American Medical Association."

The author discusses blood pressure (BP) therapy and lipid management.

The article discusses research on clinical information from 188,000 people worldwide that identified 157 genetic variants associated with lipid levels such as total cholesterol, triglyceride and high-density lipoprotein (HDL) which can provide insights for future genetic and therapeutic research.

The article reports on the studies presented at the scientific meeting of the American Heart Association which state that a new class of powerful cholesterol-reducing drugs which can be used along with statins is showing promising results. It mentions that many pharmaceutical companies including Sanofi SA, and Regeneron Pharmaceuticals Inc. are racing to bring them to the market. It notes that the most advanced of the drugs is still entering the final stages of clinical trials.

The article offers information clinical trials in lipidology, presented at the 2012 American Heart Association Scientific Sessions.

The article presents studies in lipidology reported at the American Heart Association Scientific Sessions 2011.

THE FACTS Is heart disease in the eyes? For some people, it just might be. [ABSTRACT FROM PUBLISHER]

The article emphasizes the importance of controlling lipid levels in women with cardiovascular disease (CVD).

Children who sleep less than their peers may be at greater risk for abnormal blood glucose levels and other metabolic problems. Researchers studied the sleep patterns of 308 children ages 4 to 10, half of them overweight or obese. They used wrist monitors to measure their sleep time over seven days, and did blood tests for cardiovascular risk indicators like glucose, lipids, insulin and C-reactive protein. [ABSTRACT FROM PUBLISHER]

The article focuses on the study which suggests that the onset of rotator cuff tendon tear pathology is caused by an alteration of collagenous structural arrangements with associated changes in lipids and carbohydrates, presented by Salma Chaudhury at the European Federation of National Association of Orthopaedic and Trauma (EFORT) Congress 2010.

The article reports on the findings of a study published in the "Morbidity and Mortality Weekly Report" which showed that 20% of U.S. citizens aged between 12 and 19 years have at least one abnormal lipid level while 32% of them would be good candidates for lipid screening based on current guidelines.

The article discusses research on the ability of naturally occurring lipid in the lung to prevent respiratory syncytial virus infection, conducted by a team led by M. Numata and published in a 2010 issue of "The Proceedings of the National Academy of Sciences."

The article discusses a study which examined the association between blood lipids and vascular disease, presented at the Vascular Interventional Advances 2009 meeting in Las Vegas, Nevada.

This article reports on the need for ophthalmologists to take a proactive role in the modification of their patients' behavior to prevent unnecessary vision loss, according to ophthalmologist Ian Constable. He points out that diabetes is the biggest epidemic in human history. He claims that severe vision loss can be prevented by treatment and behavior modification in the prediabetes sector of patients. He emphasizes the need to establish glucose, blood pressure and lipid control.

The article reports that the SEARCH for Diabetes in Youth Case-Control Study has found that youth with type 1 diabetes and suboptimal glycemic control had elevated lipid levels and atherogenic changes in lipoprotein profiles compared with young people without diabetes.

The article discusses the highlights of the American Academy of Optometry meeting in 2008. According to researcher Yu-Chi Tai, people who use handheld devices are encouraged to take frequent breaks and engage in more outdoor activities with distant viewing. Researchers from the Ohio State University in Columbus, reported on the correlation between lipid layers and tear film. Another study suggested that children who require vision correction should be given the option of being fitted with contact lenses.

The article focuses on the challenge of determining the effectiveness of lipid-lowering therapy in patients with moderate cardiovascular events. According to Donald M. Lloyd-James of Feinberg School of Medicine, the Framingham Risk Score/Adenosine Triphosphate (ATP) III Risk Assessment Algorithm is not useful in determination of lifetime risk. Lori Mosca of the New York Presbyterian Hospital believes that if people control their lifestyle in their 20s and 30s, adding statins in the drinking water in their 60s will not be considered.

The article relates the recommendation by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology for a comprehensive treatment regimen for patients with prediabetes. The recommendations include an intensive lifestyle management program to prevent progression to type 2 diabetes. The group also suggest that medications may be required for people with near diabetic levels of blood sugar, hypertension and abnormal lipid profiles.

BANNEDTrans fats used in preparing restaurant meals (starting in 2010) or in baked goods (in 2011). WHERE The State of California. [ABSTRACT FROM PUBLISHER]

The article discusses medical issues in the management of lipids in women. Scientific studies showed that mortality due to cardiovascular diseases (CVD) is increasing. Data from statin trials suggested that women would benefit from lipid-lowering treatments. The American Heart Association is recommending lifestyle modification and statin therapy for the control of CVD among women.

The article discusses how insulin resistance affects lipid management. Insulin resistance refers to the decrease in sensitivity to insulin-mediated glucose transport. Patients suffering from such condition are more prone to coronary heart diseases due to atherosclerosis. The primary target of lipid therapy for insulin-resistant patients is aggressive LDL (low density lipoproteins) lowering.

Focuses on fat cells. Opinion of Philipp E. Scherer, an associate professor of cell biology and medicine at Albert Einstein College of Medicine in New York; How fat cells can reflect light; Reasons why fat cells appear to be empty; How fat cells can create chemicals within the body.